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Objectives The study aimed to investigate the difference in major adverse cardiac event (MACE) at 1-year after double kissing
(DK) crush versus Culotte stenting for unprotected left main coronary artery (UPLMCA) distal bifurcation lesions.
Background DK crush and Culotte stenting were reported to be effective for treatment of coronary bifurcation lesions. How-
ever, their comparative performance in UPLMCA bifurcation lesions is not known.
Methods A total of 419 patients with UPLMCA bifurcation lesions were randomly assigned to DK (n  210) or Culotte (n 
209) treatment. The primary endpoint was the occurrence of a MACE at 1 year, including cardiac death, myocardial
infarction, and target vessel revascularization (TVR). In-stent restenosis (ISR) at 8 months was secondary endpoint,
and stent thrombosis (ST) served as a safety endpoint. Patients were stratified by SYNTAX (Synergy between Percuta-
neous Coronary Intervention with Taxus and Cardiac Surgery) and NERS (New Risk Stratification) scores.
Results Patients in the Culotte group had significant higher 1-year MACE rate (16.3%), mainly driven by increased TVR
(11.0%), compared with the DK group (6.2% and 4.3%, respectively; all p  0.05). ISR rate in side branch was
12.6% in the Culotte group and 6.8% in the DK group (p  0.037). Definite ST rate was 1.0% in the Culotte
group and 0% in the DK group (p  0.248). Among patients with bifurcation angle 70°, NERS score 20, and
SYNTAX score 23, the 1-year MACE rate in the DK group (3.8%, 9.2%, and 7.1%, respectively) was significantly
different to those in the Culotte group(16.5%, 20.4%, and 18.9%, respectively; all p  0.05).
Conclusions Culotte stenting for UPLMCA bifurcation lesions was associated with significantly increased MACEs, mainly due to the in-
creased TVR. (Double Kissing [DK] Crush Versus Culotte Stenting for the Treatment of Unprotected Distal Left Main Bifurca-
tion Lesions: DKCRUSH-III, a Multicenter Randomized Study Comparing Double-Stent Techniques; ChiCTR-TRC-
00000151) (J Am Coll Cardiol 2013;61:1482–8) © 2013 by the American College of Cardiology Foundation
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April 9, 2013:1482–8 DK Crush Versus Culotte Stenting for UPLMCAUnprotected left main coronary artery (UPLMCA) patients
with lower risk scores (1–4) or lesions that are ostial or
midshaft (5,6) appear to have comparative outcomes after
drug-eluting stent placement to the coronary artery bypass
graft (CABG) (1–3). By contrast, distal UPLMCA bifur-
cation lesions are technically demanding, often requiring
double stenting and resulting in less favorable long-term
outcomes (3,5–8). Previous studies showed that double
kissing (DK) crush and Culotte stenting were effective for
coronary artery bifurcation lesions (9–12), but, their dura-
bility and safety have never been randomly compared. Thus,
we designed this DKCRUSH (DK Crush Versus Culotte
Stenting for the Treatment of Unprotected Distal Left
Main Bifurcation Lesions)-III study aiming to analyze the
difference in the MACE between DK crush versus Culotte
stenting for UPLMCA distal bifurcation lesions.
Methods
Patient population and randomization. The DKCRUSH-
III study was conducted in 18 centers. The protocol was
approved by the ethics committee and institutional research
board, and written consent was obtained from all patients.
Inclusion criteria were as follows: age 18 years, Medina
13) 1,1,1 or 0,1,1 de novo UPLMCA bifurcation lesions,
nd chronic total occlusion (2) in any parent vessel after
uccessful recanalization. Clinical and angiographic exclusion
riteria were demonstrated in Figure 1. Additional exclusion
riteria included pregnancy, a platelet count 10  109/l and
uspected intolerance to 1 of the study drugs.
The participants were randomly assigned in a 1:1 ratio to
ither the DK or Culotte group.
Figure 1 Flowchart of Study Design
AMI  acute myocardial infarction; DK  double kissing; eGFR  estimated glome
LM  left main artery; LVEF  left ventricular ejection fraction; PCI  percutaneou
main coronary artery.rocedure and medications.
K crush and Culotte stenting
echniques (Fig. 2) have been de-
cribed previously (11,14). The can-
idate stents were Firebird-2 (Mi-
roport Co., Shanghai, China) and
ience V (Abbott Vascular,
alifornia).
A 300-mg loading dose of
lopidogrel was administered be-
ore the index procedure. After
he intervention, all patients re-
eived 100 mg/day aspirin for life
nd clopidogrel (75 mg/day) for
t least 12 months.
ollow-up protocol. Clinical
ollow-up was performed with
ffice visits or telephone contact
t 1, 6, and 12 months. Follow-up coronary angiography was
cheduled at 8 months after the index procedure unless
linical reasons indicated earlier.
Serial quantitative coronary analysis was analyzed accord-
ng to our previous methods (14).
tudy endpoints and definitions. The primary endpoint
as the occurrence of 1-year major adverse cardiac event
MACE) rate, including myocardial infarction, cardiac
eath, and/or target vessel revascularization (TVR). Sec-
ndary endpoint was in-stent restenosis (ISR). Stent
hrombosis (ST) served as a safety endpoint. ST, myo-
ardial infarction, cardiac death, target lesion revascular-
zation (TLR), and TVR were defined according to the
cademic Research Consortium definition (15).
Abbreviations
and Acronyms
CABG  coronary artery
bypass graft
DK  double kissing
ISR  in-stent restenosis
MACE  major adverse
cardiac event
SB  side branch
ST  stent thrombosis
TLR  target lesion
revascularization
TVR  target vessel
revascularization
UPLMCA  unprotected
left main coronary artery
filtration rate; LAD  left anterior descending artery; LCX  left circumflex artery;
nary intervention; RVD  reference vessel diameter; UPLMCA  unprotected leftrular
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DK Crush Versus Culotte Stenting for UPLMCA April 9, 2013:1482–8Sample size calculation and statistical analysis. We hy-
pothesized that the rate of a 1-year MACE rate would be
5% in the DK crush and 15% in the Culotte groups.
Accordingly, a total sample size of 358 was needed to detect
a power of 0.8 (Type II error  0.20,   .05, 2-tailed).
ecause of the considerable uncertainty, the enrollment was
xtended to 420 patients (15% increment). The treatment-
roup differences were evaluated with a student t test or
ilcoxon rank sum scores for continuous variables when
ppropriate. The chi-square test or the Fisher exact test was
sed to analyze categorical variables. Rate-free survival from
vents were generated by Kaplan-Meier analysis, and they were
ompared using the log-rank test. Four pre-specified subgroup
nalyses by Forest plot were planned to be performed. Statis-
ical significance was taken as a p value 0.05. All analyses
ere performed with the statistical program SPSS version 16.0
SPSS Institute Inc., Chicago, Illinois).
esults
aseline and procedural characteristics. Baseline clinical
Table 1), lesions (Table 2), and procedural (Table 3)
haracteristics were well matched between 2 treatment
roups. All continuous variables were normally distributed.
linical outcomes. By 12-month follow-up, there were 34
Figure 2 Schematic Description of DK Crush and Culotte Stent
For the double kissing (DK) crush technique, 2 injections (A, B) showed a Medina 1,1
(C) through a 6-F guiding catheter, a 2.5  23 mm Firebird-2 (Microport Co., Shangha
into LM) and a 3.0  12 mm Sprinter balloon was positioned in the left anterior desc
(F); a 2.5  15-mm noncompliant balloon inflated by 16 atm was done after rewiring
crossover from LAD to LM (H); after rewiring LCX, sequential inflation by at least 16 a
tion (K). The final result was acceptable (L). For Culotte stenting, spider-view showed
Xience stent (Abbott Vascular, California) was inflated in the LAD-LM (b) (LAD was trea
ing LAD stent struts (d) facilitated the advancement of a 3.0  23 mm Xience stent i
(f); alternative inflation at 16 atm using noncompliant balloon started from LCX (g) (3
diameter noncompliant balloon did not pass through the stent cell) was performed, fo
LAD, alternative inflation (j) in LAD was followed by final kissing balloon inflation (k). F16.3%) composite MACEs in the Culotte group and 13 C6.2%) in the DK group (p  0.001), mainly because of
ignificantly increased TLR (6.7%) and TVR (11%) in the
ulotte group (2.4%, p  0.037) compared with the DK
roup (4.3%, p 0.016) (Table 4, Figs. 3, 4, and 5). Among
atients with distal bifurcation angle 70°, NERS (New
isk Stratification) score20 and SYNTAX score23, the
ncidence of the composite MACE in the DK group was
ignificantly lower than that in the Culotte group (Fig. 6).
tent thrombosis. By 12 months, the incidence of definite
T was 1.0% (n  2) in the Culotte group and 0% in the
K group (p  0.623).
uantitative coronary analysis. There were 12 (6.8%)
SR at side branch (SB) in the DK group and 22 (12.6%) in
he Culotte group (p  0.037), mostly seen at ostial SB
Table 5).
iscussion
he major finding was that Culotte stenting was associated
ith significantly increased 1-year composite MACE rate,
ainly because of the increment of TVR rate.
For UPLMCA bifurcation lesions, single-stent strategy
as superior to systematic double-stent (including
-stenting, kissing stenting) techniques (3–6). Actually,
echniques via a Transfemoral Approach
al left main (LM) bifurcation lesions; after pre-dilation using kissing balloon inflation
a) stent (D, E) was inflated in the left circumflex artery (LCX) (with 1-mm protrusion
artery (LAD) (D, E); balloon crush was performed immediately after stenting LCX
llowed by fist kissing inflation (G); a 3.0  28 mm Firebird-2 stent was inflated
rted from LCX (I) then LAD (J) was performed, followed by final kissing balloon infla-
ina 1,1,1 distal left main bifurcation lesions (a); after pre-dilation, a 2.5  23 mm
side branch); rewiring LCX and post-dilation for LAD stent was performed (c); open-
X (e), post-stenting LCX result was good but ostial LAD seemed to be compromised
2 mm NC Sprinter) then LAD (h) (2.5  12 mm NC Sprinter, because a 3.0 mm in
by kissing inflation (i); then, a 3.0  12 mm NC Sprinter balloon was positioned in
sults were acceptable (l).ing T
,1 dist
i, Chin
ending
LCX, fo
tm sta
a Med
ted as
nto LC
.0  1
llowed
inal reulotte stenting is a reverse T stenting, by which intrapro-
L
i
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April 9, 2013:1482–8 DK Crush Versus Culotte Stenting for UPLMCAcedural acute closure of the main vessel after stenting SB is
unavoidable (14,16), this rate was 1% in the present study,
which might be catastrophic for distal left main, as we
showed that 1 patient died soon after LAD closure. In the
ISAR-LEFT MAIN study (12), 98% of 384 patients with
distal UPLMCA lesions were treated by Culotte stenting,
the 1-year MACE (15.8%) and ISR (19.4%) in the cypher
group were compared well with the current study (14.4% vs.
12.6%, respectively). Except for the limitation of the cypher
stent design (close cell) for bifurcation lesions (17), we
might be of great courage to postulate that the ISR rate
would become significantly higher if distal bifurcation
subgroup was analyzed in that study. Our finding, restenotic
lesions are most localized in the SB, is consistent with the
previous results (11,12). Thus, we have to say that DK crush
is superior to Culotte stenting when bearing in mind that
patients in the ISAR-LEFT MAIN study (12) were less at
risk compared with the current study. Bench test (17) and
intravascular ultrasound findings (18,19) reported that a
“napkin” or a gap or a metallic ridge is usually seen at the
ostial SB after Culotte stenting, leading to the failure to
fully cover the ostial SB and resulting in increased ISR and
TLR. In contrast, DK crush introduced 2 times of kissing
balloon inflation, allowed the full coverage of ostial SB,
resulting in less ISR (4,14).
The sustained durability of DK crush was demon-
Baseline Clinical CharacteristicsTable 1 Baseline Clinical Characteristics
DK Group
(n  210)
Culotte Group
(n  209) p Value
Male 162 (77.1) 167 (79.9) 0.552
Age, yrs 64.3 10.3 63.3 9.2 0.296
Body mass index, kg/m2 24.63 3.46 24.83 3.20 0.314
Hypertension 148 (70.5) 128 (61.2) 0.055
Hyperlipidemia 87 (41.4) 88 (42.1) 0.921
Cholesterol, mmol/l 4.37 1.05 4.36 1.03 0.666
LDL, mmol/l 2.70 0.82 2.69 0.94 0.776
Diabetes 67 (31.9) 63 (30.1) 0.298
Fasting glucose, mmol/l 6.37 3.35 6.31 3.66 0.506
Smoking 0.914
Current smoking 58 (27.6) 54 (25.8)
Quit smoking 37 (17.6) 37 (17.7)
2-week acute MI 18 (8.6) 12 (5.7) 0.344
Previous MI 32 (15.2) 29 (13.9) 0.258
Unstable angina 165 (78.6) 174 (83.3) 0.263
Stable angina 21 (10.0) 20 (9.6) 1.000
Silent ischemia 6 (2.9) 3 (1.4) 0.503
Previous PCI 47 (22.4) 31 (14.8) 0.059
LVEF, % 58.7 11.3 58.8 10.6 0.296
40% 18 (8.6) 9 (4.3) 0.110
eGFR, ml/min/1.73 m2 84.97 21.89 83.39 22.09 0.463
40 ml/min 0 (0) 6 (2.9)
40-59 ml/min 28 (13.3) 21 (10.0)
Values are mean  SD or n (%).
DK double kissing; eGFR estimated glomerular filtration rate; LDL low-density lipoprotein;
VEF  left ventricular eject fraction; MI  myocardial infarction; PCI  percutaneous coronary
ntervention.strated in patients at intermediate- and high-risk strati-fied by either NERS or SYNTAX score. Furthermore,
clinical efficacy of DK crush is also maintained in the
patients with distal bifurcation angle 70°. The contro-
versy of whether there is a correlation of bifurcation angle
with worse outcome has existed for a long time (20). We
postulate that the abnormal hemodynamic change of
shear stress induced by Culotte stenting might play a
central role in the occurrence of ISR.
For bifurcation lesions, a complex stenting approach has
been an independent factor for ST (8,16), although there is
no convinced data after stenting distal UPLMCA bifurca-
tion lesions. Similar to ST rate (1%) by the ISAR-LEFT
MAIN trial (12), ST rate (1.0%) after Culotte stenting in
the present study was slightly lower than the 1.9% reported
by Erglis et al. (9) and 1.6% by Adriaenssens et al. (11). It
might be plausible that both DK crush and culotte stenting
techniques are safe for distal UPLMCA bifurcation lesions,
and that optimizing the expansion of the SB stent, as did
the DK crush technique, would have put patients at lower
risk of ST.
Lesions CharacteristicsTable 2 Lesions Characteristics
DK Group
(n  210)
Culotte Group
(n  209) p Value
3-vessel disease 149 (71.3) 145 (69.5) 0.130
LAD 64 (30.5) 58 (27.6)
LCX 36 (17.6) 45 (21.8)
RCA 58 (27.6) 60 (28.7)
Left main trunk
Chronic total occlusion 1 (0.4) 0 (0) 0.653
Ostial 31 (15.2) 42 (20.4) 0.197
Midshaft 71 (34.8) 60 (28.7) 0.102
Whole trunk 45 (21.8) 39 (18.9) 0.159
Distal bifurcation 0.896
Medina 1,1,1 207 (98.7) 198 (94.8)
Medina 0,1,1 3 (1.3) 11 (5.2)
LAD*
Severe tortuous 25 (11.9) 28 (13.4) 0.662
Mild-moderate calcification 30 (14.3) 30 (14.4) 1.000
Thrombus-containing 0 (0) 0 (0) NS
Chronic total occlusion 10 (4.8) 12 (5.7) 0.209
TIMI flow grade 0–2 23 (10.9) 20 (9.6) 0.320
LCX*
Severe tortuous 38 (18.1) 45 (21.5) 0.393
Mild-moderate calcification 19 (9.1) 20 (9.6) 0.786
Thrombus-containing 0 (0) 0 NS
Chronic total occlusion 9 (4.3) 12 (5.7) 0.512
TIMI flow grade 0–2 19 (9.1) 22 (10.5) 0.280
IVUS assessment 145 (69.0) 154 (73.7) 0.331
SYNTAX score (points) 30.67 12.89 31.51 15.60 0.254
0–22 69 (32.9) 54 (25.8) 0.462
NERS score (points) 26.03 10.70 26.12 10.55 0.677
20 55 (26.2) 47 (22.5) 0.241
Values are n (%) or mean SD. *Left anterior descending artery (LAD) was treated as main branch
in all patients, with exception for 3 in the DK group and 2 in the culotte group, for whom the left
circumflex artery (LCX) was considered the main branch.
IVUS  intravascular ultrasound; NERS  New Risk Stratification; RCA  right coronary artery;
SYNTAX  Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery;
TIMI  Thrombolysis In Myocardial Infarction; other abbreviations as in Table 1.
TLR target lesion revascularization; TVR target vessel revascularization; other abbreviations as
FKBI  final kissing balloon inflation; IABP  intra-aortic balloon pump; other abbreviations as
in Table 1.
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DK Crush Versus Culotte Stenting for UPLMCA April 9, 2013:1482–8Figure 3 TLR-Free Survival Rate at 12 Months
Rate was 93.3% in the Culotte group, and 97.6% in the double
kissing (DK) group (p  0.034). TLR  target lesion revascularization.Figure 4 TVR-Free Survival Rate at 12 Months
Rate was 89.0% in the Culotte group, and it was 95.7% in the double
kissing (DK) group (p  0.016). TVR  target vessel revascularization.
in Tables 1 and 2.Clinical Follow-UpTable 4 Clinical Follow-Up
DK Group
(n  210)
Culotte Group
(n  209) p Value
In-hospital
In-hospital days 6.58 4.31 7.19 3.94 0.134
Composite MACE 7 (3.3) 8 (3.8) 0.800
Cardiac death 1 (0.5) 1 (0.5) 1.000
MI 7 (3.3) 8 (3.8) 0.800
TLR 0 (0) 0 (0) NS
TVR 0 (0) 0 (0) NS
CABG 0 (0) 0 (0) NS
Stent thrombosis 0 (0) 0 (0) NS
Procedural success 203 (96.7) 201 (96.2) 0.800
At 1 month
Composite MACE 7 (3.3) 9 (4.3) 0.622
Cardiac death 1 (0.5) 1 (0.5) 1.000
MI 7 (3.3) 9 (4.3) 0.622
TLR 0 (0) 1 (0.5) 0.499
TVR 0 (0) 1 (0.5) 0.499
CABG 0 (0) 0 (0) NS
Stent thrombosis 0 (0) 1 (0.5) 0.499
Definite 0 (0) 1 (0.5) 0.499
Probable 0 (0) 0 (0) NS
At 12 months
Composite MACE 13 (6.2) 34 (16.3) 0.001
Cardiac death 2 (1.0) 2 (1.0) 1.000
MI 7 (3.3) 11 (5.3) 0.377
TLR 5 (2.4) 14 (6.7) 0.037
TVR 9 (4.3) 23 (11.0) 0.016
For LAD 0 (0) 4 (1.9) 0.061
For LCX 1 (0.5) 2 (1.0) 0.623
For left main 9 (4.3) 20 (9.6) 0.036
CABG 2 (1.0) 0 (0) 0.499
Stent thrombosis 1 (0.5) 2 (1.0) 0.623
Definite 0 (0) 2 (1.0) 0.248
Probable 0 (0) 0 (0) NS
Possible 1 (0.5) 0 (0) 1.000
Values are mean  SD or n (%) .
CABG coronary artery bypass graft; MACEmajor adverse cardiac event; NS not significant;Procedural CharacteristicsTable 3 Procedural Characteristics
DK Group
(n  210)
Culotte Group
(n  209) p Value
Transradial approach 122 (58.1) 123 (58.9) 0.976
IIb/IIIa used 35 (16.7) 39 (18.7) 0.834
Supported device
IABP 6 (2.9) 7 (3.3) 0.860
Impella 3 (1.4) 3 (1.5) 0.989
Stent types 0.703
Firebird-2 78 (37.1) 75 (35.9)
Xience V 132 (62.9) 134 (64.1)
Post-dilation
Main vessel 205 (97.6) 200 (95.7) 0.693
Side branch 202 (96.2) 200 (95.7) 0.810
FKBI 209 (99.5) 208 (99.5) 1.000
Main vessel stent
n 1.38 0.45 1.39 0.49 0.556
Diameter, mm 3.40 0.34 3.34 0.40 0.106
Length, mm 33.48 14.01 35.74 15.99 0.124
Side branch stent
n 1.20 0.39 1.14 0.35 0.159
Diameter, mm 3.04 0.41 3.03 0.41 0.587
Length, mm 25.90 13.83 26.72 11.86 0.519
Angiographic success 204 (97.1) 208 (99.5) 0.122
Complete revascularization 201 (95.7) 201 (96.2) 0.755
Procedural time, min 56.88 33.11 54.87 32.09 0.529
Fluoroscopy time, min 26.57 14.39 27.66 17.53 0.487
Contrast volume, ml 184.40 22.01 170.10 7.22 0.048
Non–left main lesions
Stent number 1.41 0.73 1.26 0.53 0.410
Stent diameter, mm 2.89 0.42 2.99 0.46 0.468
Stent length, mm 36.86 27.33 32.33 15.34 0.468
Values are n (%) or mean  SD.
2 in the DK group and 1 in the Culotte group, for whom LCX was considered as main vessel.
Abbreviations as in Tables 1 and 2.
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April 9, 2013:1482–8 DK Crush Versus Culotte Stenting for UPLMCAStudy limitations. Some kind of angle restriction should
have been applied in the design of the study. We did not
include a CABG group to contrast with the stenting
techniques. However, the promising results achieved by the
DK crush technique were comparable with those after
CABG. Finally, the results were achieved in very high-
volume operators performing these procedures. It remains
unclear whether lower volume centers could reproduce these
results.
Conclusions
Compared to the DK crush technique, Culotte stenting is
associated with significantly increased MACEs in patients
with UPLMCA bifurcation lesions.
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Figure 5 MACE-Free Survival Rate at 12 Months
Rate was 83.7% in the Culotte group, and it was 93.8% in the double
kissing (DK) group (p  0.001). MACE  major adverse cardiac event.
Figure 6 Forest Plots of 1-Year MACE Rate in Pre-Specified Subg
Among patients with distal bifurcation angle 70°, NERS (New Risk Stratification) sco
Cardiac Surgery) 23, the incidence of the composite major adverse cardiac events (
to 16.5% (p  0.001), 20.4% (p  0.014), and 18.9% (p  0.006) in the Culotte groroups
re 20, and SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and
MACE) (3.8%, 9.2%, and 7.1%) in the double kissing (DK) group was significantly different
up, respectively. CI  confidence interval; M-H  Mantel-Haenszel.Quantitative Coronary Analysisfor Main Vessel a d Side BranchTable 5 Quantitat v Coronary Analysisfor Main Vessel and Side Branch
DK Group
(n  176)
Culotte Group
(n  174) p Value
Days from indexed procedure 223.0. 15.3 211.9 14.1 0.109
Left main trunk
Lesion length, mm 6.36 3.69 6.97 3.86 0.100
Minimal lumen diameter, mm
Prior stenting 1.47 0.43 1.49 0.42 0.719
Acute gain 2.34 0.47 2.34 0.49 0.980
Late loss 0.18 0.29 0.23 0.34 0.378
Diameter stenosis
Prior stenting 59.84 9.35 59.18 8.47 0.772
Follow-up 11.08 7.24 11.81 6.83 0.401
Restenosis 0 0 NS
LAD*
Lesion length, mm 16.67 9.23 18.65 12.26 0.067
Minimal lumen diameter, mm
Prior stenting 1.09 0.42 1.07 0.44 0.984
Acute gain 1.79 0.41 1.79 0.42 0.988
Late loss 0.19 0.32 0.20 0.33 0.938
Diameter stenosis
Prior stenting 64.62 5.66 65.69 6.46 0.414
Follow-up 16.15 8.33 15.41 7.10 0.622
Restenosis 2 (1.14) 1 (0.57) 1.000
LCX*
Lesion length, mm 16.48 11.09 16.97 13.01 0.804
Minimal lumen diameter, mm 0.597
Prior stenting 1.01 0.43 1.07 0.49 0.990
Acute gain 1.58 0.43 1.58 0.49
Late loss
In-stent 0.20 0.30 0.39 0.36 0.001
In-segment 0.09 0.21 0.21 0.30 0.048
Diameter stenosis
Prior stenting 65.29 7.34 63.36 7.75 0.640
Follow-up 16.39 7.45 25.50 7.36 0.001
Restenosis 12 (6.82) 22 (12.64) 0.037
In-segment 4 (2.27) 6 (3.45) 0.540
In-stent 9 (5.11) 19 (10.92) 0.034
Ostial 9 (5.11) 16 (9.19) 0.045
Values are mean SD or n (%). *LAD was treated as main vessel in all patients, with exception for
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